Total, LDL, and HDL cholesterol decrease with age in older men and women: The Rancho Bernardo Study 1984-1994

Circulation

Volumn 96, Issue 1, 1997, Pages 37-43

  Ferrara, Assiamira ^a,b   Barrett Connor, Elizabeth ^a,c   Shan, Jun ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DIVISION OF RESEARCH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aging; Lipids; Population studies; Weight change

Indexed keywords

ALCOHOL; ANTILIPEMIC AGENT; CHOLESTEROL; ESTROGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THIAZIDE DIURETIC AGENT; THYROID HORMONE;

ADULT; AGE; AGED; AGING; ARTICLE; BODY MASS; ESTROGEN THERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; SMOKING CESSATION; WEIGHT;

EID: 0030818676     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.1.37     Document Type: Article

References (54)

1. Heiss G, Tamir I, Davis CE, Tyroler HA, Rifkind BM, Schonfeld G, Jacobs D, Frantz ID. Lipoprotein-cholesterol distributions in selected North America populations: the Lipid Research Clinics Program Prevalence Study. Circulation. 1980;61:302-315.
2. Moulopoulos SD, Andamopoulos PN, Diamantopoulos EI, Nanas SN, Anthopoulos LN, Iliadi-Alexandrou M. Coronary heart disease risk factors in a random sample of Athenian adults: the Athens Study. Am J Epidemiol. 1987;126:882-892.
3. Heitmann BL. The effects of gender and age on associations between blood lipid levels and obesity in Danish men and women aged 35-65 years. J Clin Epidemiol. 1992;45:693-702.
4. Schaefer EJ, Lamon-Fava S, Cohn SD, Schaefer MM, Ordovas JM, Castelli WP, Wilson PWF. Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study. J Lipid Res. 1994;35:779-792.
5. Clark D, Allen MF, Wilson FH. Longitudinal study of serum lipids. Am J Clin Nutr. 1967;20;743-752.
6. Hershcopf RJ, Elahi D, Andres R, Baldwin HL, Raizes GS, Schocken DD, Tobin JD. Longitudinal changes in serum cholesterol in men: an epidemiological search for an etiology. J Chron Dis. 1982;35:101-114.
7. Criqui MH, Frankville DD, Barrett-Connor E, Klauber MR, Holdbrook MJ, Turner JD. Change and correlates of change in high and low density lipoprotein cholesterol after six years: a prospective study. Am J Epidemiol. 1983;118:52-59.
8. Anderson KM, Wilson PWF, Garrison RJ, Castelli WP. Longitudinal and secular trends in lipoprotein cholesterol measurements in a general population sample: the Framingham offspring study. Atherosclerosis. 1987;68:59-66.
9. Hubert HB, Eaker ED, Garrison RJ, Castelli WP. Life-style correlates of risk factor change in young adults: an eight-year study of coronary heart disease risk factors in the Framingham offspring. Am J Epidemiol. 1987;125:812-831.
10. Berns MA, De Vries JHM, Katan MB. Increase in body fatness as a major determinant of change in serum total cholesterol and high density lipoprotein cholesterol in young men over a 10-year period. Am J Epidemiol. 1989;130:1109-1122.
11. Eberle E, Doering A, Keil U. Weight change and change in total cholesterol and high-density-lipoprotein cholesterol: results of the MONICA Augsburg Cohort Study. Ann Epidemiol. 1991;1:487-492.
12. Wilson PWF, Anderson KM, Harris T, Kannel WB, Castelli WP. Determinants of change in total cholesterol and HDLC with age: the Framingham study. J Gerontol. 1994;49:M252-M257.
13. The Lipid Research Clinics Program Epidemiology Committee. Plasma lipid distributions in selected North America populations: the Lipid Research Clinics Program Prevalence Study. Circulation. 1979;60:427-439.
14. Abbott RD, Garrison RJ, Wilson PW, Epstein FH, Castelli WP, Feinleib M, LaRue C. Joint distribution of lipoprotein cholesterol classes: the Framingham Study. Arteriosclerosis. 1983;3:260-272.
15. Laurenzi M, Mancini M. Plasma lipids in elderly men and women. Eur Heart J. 1988:9(suppl D):69-74.
16. Kromhout D, Nissinen A, Menotti A, Bloemberg B, Pekkanen J, Giampaoli S. Total and HDL cholesterol and their correlates in elderly men in Finland, Italy, and Netherlands. Am J Epidemiol. 1990;131:855-863.
17. Wallance RB, Colsher PL: Blood lipids distributions in older persons: prevalence and correlates of hyperlipidemia. Ann Epidemiol. 1992;2:15-21.
18. Ettinger WH, Wahl PW, Kuller LH, Bush TL, Trucy RP, Manolio TA, Borhami NO, Wong ND. O'Leary DH, for the CHS Collaborative Research Group. Lipoprotein lipids in older people: results from the Cardiovascular Health Study. Circulation. 1992;86: 858-869.
19. Curb DJ, Reed DM, Yano K, Kautz JA, Albers JJ. Plasma lipids and lipoproteins in elderly Japanese-American men. J Am Geriatr Soc. 1986;34:773-780.
20. Newschaffer CJ, Bush TL, Hale W: Aging and total cholesterol levels: cohort, period, and survivorship effects. Am J Epidemiol. 1992;136:23-34.
21. Frishman WH, Ooi WL, Derman MP, Eder HE, Gidez LI, Ben-Zeev D, Zimetbaun P, Heiman M, Aronson M. Serum lipids and lipoprotein in advanced age: intraindividual changes. Ann Epidemiol. 1992;2:43-50.
22. Garry PJ, Hunt WC, Koehler KM, VanderJagt DJ, Vellas BJ. Longitudinal study of dietary intakes and plasma lipids in healthy elderly men and women. Am J Clin Nutr. 1992;55:682-688.
23. Weijenberg MP, Feskens EJ, Kromhout D. Age-related changes in total and high-density-lipoprotein cholesterol in elderly Dutch men. Am J Public Health. 1996;86:798-803.
24. Wingard DL, Sinsheimer P, Barrett-Connor EL, McPhillips JB. Community-based study of prevalence of NIDDM in older adults. Diabetes Care. 1990;13(suppl 2):3-8.
25. National Heart and Lung Institute, Lipid Research Clinics Program Laboratory Methods Committee. Manual of Laboratory Operations: Lipid and Lipoprotein Analysis, ed 2. Washington, DC: US Government Printing Office; 1974, DHEW publication No. 75-628.
26. Friedewald WJ, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 1972;18:459-502.
27. Mee RW, Chua TC. Regression toward the mean and the paired sample t test. Am Stat. 1991;45:39-42.
28. SAS Institute Inc. SAS/STAT User' s Guide, Version 6, ed 4. Cary, NC: SAS Institute; 1989.
29. Brownell KD, Stunkard J. Differential changes in plasma high-density lipoprotein-cholesterol levels in obese men and women during weight reduction. Arch Intern Med. 1981;141:1142-1146.
30. Zimmerman J, Kaufmann NA, Fainaru M, Eisenberg S, Oschry Y, Friedlander Y, Stein Y. Effect of weight loss in moderate obesity on plasma lipoprotein and apolipoprotein levels and on high density lipoprotein composition. Arteriosclerosis. 1984;4:115-123.
31. Wing RR, Jeffery RW, Burton LR, Thorson C, Kuller LH, Folsom AR. Change in waist-hip ratio with weight loss and its association with change in cardiovascular risk factors. Am J Clin Nutr. 1992;55: 1086-1092.
32. Katzel LI, Bleecker ER, Colman EG, Rogous EM, Sorkin JD, Goldeberg AP. Effect of weight loss vs aerobic exercise training on risk factors for coronary disease in healthy, obese middle-aged and older men: a randomized controlled trial. JAMA. 1995;274:1915-1921.
33. Borkan GA, Hults DE, Gerzof SG, Robbins AH, Silbert CK. Age changes in body composition revealed by computer tomography. J Gerontol. 1983;38:673-677.
34. Flynn MA, Nolph GB, Baker AS, Krause G. Aging in humans: a continuous 20-year study of physiologic and dietary parameters. J Am Coll Nutr. 1992;11:660-672.
35. Hallfrish J, Muller D, Drinkwater D, Tobin J, Andres R. Continuing diet trends in men: the Baltimore Longitudinal Study of Aging (1961-1978). J Gerontol. 1990;45:M186-M191.
36. Ferrini RL, Edelstein SL, Barrett-Connor E. Factors associated with health behavior change among residents 50 to 96 years of age in Rancho Bernardo, California. Am J Prev Med. 1994;10:26-30.
37. Kuller LH, Hulley SB, La Porte RE, Neaton J, Dai WS. Environmental determinants, liver function, and high density lipoprotein cholesterol levels. Am J Epidemiol. 1983;117:406-418.
38. Shennan NM, Seed M, Wynn V. Variation in serum lipid and lipoprotein levels associated with changes in smoking behavior in non-obese Caucasian males. Arteriosclerosis. 1985;58;17-25.
39. Williams PT, Wood PD, Krauss RM, Haskell WL, Vranizam KL, Blair SN, Terry R, Farquhar JW. Does weight loss cause the exercise-induced increase in plasma high density lipoproteins? Atherosclerosis. 1983;47:173-185.
40. Williams PT, Wood PD, Haskell WL, Vranizan K. The effects of running mileage and duration on plasma lipoprotein levels. JAMA. 1982;247:2674-2679.
41. Grundy SM, Denke MA. Dietary influences on serum lipids and lipoproteins. J Lipid Res. 1990;31:1149-1172.
42. Ettinger WH, Harris T. Causes of hypocholesterolemia. Coron Artery Dis. 1993;4:854-859.
43. Iribarren C, Reed DM, Chen R, Yano K, Dwyer JH. Low serum cholesterol and mortality: which is the cause and which is the effect? Circulation. 1995;92:2396-2403.
44. Pekkanen J, Nissenen A, Vartiainen E, Salonen JT, Punsar S, Karvonen MJ. Changes in serum cholesterol level and mortality: a 30 year follow-up: the Finnish cohort of the Seven Countries Study. Am J Epidermiol. 1994; 139:155-165.
45. Gylling H, Standemberg T, Tilvis R, Miettimen TA. Regulation of serum cholesterol level in middle-aged and elderly men: relation of cholesterol absorption and synthesis to lipoprotein metabolism. Arterioscler Thromb. 1994:694-700.
46. Manolio TA, Pearson TA, Wenger NK, Barrett-Connor E, Payne GH, Harlan WR. Cholesterol in older persons and women: review of an NHLBI workshop. Ann Epidemiol. 1992;2:161-176.
47. Krumholz HM, Seeman TE, Merrill SS, Mendes de Leon CF, Vaccarino V, Silverman DI, Tsukahara R, Ostefeld A, Berkman LF. Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause of mortality in persons older than 70 years. JAMA. 1994;272:1335-1340.
48. Denke MA, Winker MA. Cholesterol and coronary heart disease in older adults: no easy answers. JAMA. 1995;274:575-577.
49. Corti M-C, Guralnik JM, Salive ME, Harris T, Field TS, Wallace RB, Berkman LF, Seeman TE, Glynn RJ, Hennekens CH, Havlik RJ. HDL cholesterol predicts coronary heart disease mortality in older persons. JAMA. 1995;274:539-544.
50. Weijenberg MP, Feskens EJ, Bowles CH, Kromhout D. Serum total cholesterol and systolic blood pressure as risk factor for mortality from ischemic heart disease among elderly men and women. J Clin Epidemiol. 1994;47:197-205.
51. Jacobs D, Blackburn H, Higgins M, Reed D, Iso H, McMillan G, Neaton J, Nelson J, Potter J, Rifkind B, Rossouw J, Shekelle R, Yusuf S, for participants in the Conference on Low Cholesterol: Mortality association: report of the Conference on Low Blood Cholesterol: Mortality Associations. Circulation. 1992;86:1046-1060.
52. Iribarren C, Reed DM, Burchfiel CM, Dwyer JH. Serum total cholesterol and mortality: confounding factor and risk modification in Japanese-American men. JAMA. 1995;273:1926-1932.
53. Scandinavian Sinvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Sinvastatin Survival Study (4S). Lancet. 1994;344: 1383-1389.
54. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macfarlane PW, McKillop JH, Packard CJ, for the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995; 333:1301-1307.